Evidence map›Paper›PMID 40283108›Full record

ArticleLife (Basel, Switzerland)2025

Comparative Vascular Effects of Sirolimus and Everolimus on Isolated Human Saphenous Veins.

Deniz Kaleli Durman, Erkan Civelek, Fatoş İlkay Alp Yildirim, Önder Teskin, Birsel Sönmez Uydeş Doğan

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Deniz Kaleli DurmanDepartment of Pharmacology, Faculty of Pharmacy, Istanbul University, 34116 Istanbul, Türkiye.ORCID 0000-0002-8669-7480
Erkan CivelekDepartment of Pharmacology, Faculty of Pharmacy, Istanbul University, 34116 Istanbul, Türkiye.
Fatoş İlkay Alp YildirimDepartment of Pharmacology, Faculty of Pharmacy, Istanbul University, 34116 Istanbul, Türkiye.ORCID 0000-0001-5695-5269
Önder TeskinDepartment of Cardiovascular Surgery, Faculty of Medicine, Biruni University, 34015 Istanbul, Türkiye.
Birsel Sönmez Uydeş DoğanDepartment of Pharmacology, Faculty of Pharmacy, Istanbul University, 34116 Istanbul, Türkiye.ORCID 0000-0002-6729-8150

Funding

This study was funded by Scientific Research Projects Coordination Unit of Istanbul University. Project number: 24947
6 · The paper itself

Abstract

Drug-eluting stents, which release antiproliferative agents such as sirolimus and everolimus, were developed to reduce the risk of restenosis associated with bare-metal stents. However, despite their proven clinical efficacy, concerns remain regarding in-stent restenosis due to delayed endothelial healing and the risk of late thrombotic events. In this study, we aimed to determine the vascular effects of sirolimus and everolimus on isolated human saphenous vein (SV) samples obtained from patients undergoing coronary artery bypass surgery. SV rings were subjected to sirolimus and everolimus in acute and pretreatment conditions in vitro. Increasing concentrations of sirolimus (10

Indexed as

drug-eluting stentseverolimushuman saphenous veinsirolimusvascular tone

Identifiers

PMID40283108
PMCPMC12028532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.